A new process for preparing 4- [4-methyl-5- (Cl10alkylthio/C5-10aryl-Cl-6alkylthio) - 4H-1, 2, 4-triazol-3YL] pyridines.

Details for Australian Patent Application No. 2009325178 (hide)

Owner AstraZeneca AB

Inventors Astrom, Hans; Jones, Elfyn; Stahlberg, Tim

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009325178

PCT Pub. Number WO2010/068172

Priority 61/122,044 12.12.08 US

Filing date 11 December 2009

Wipo publication date 17 June 2010

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 249/12 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

Event Publications

16 June 2011 PCT application entered the National Phase

  PCT publication WO2010/068172 Priority application(s): WO2010/068172

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009325182-Method for stimulating biodegradation and the degassing of waste disposal sites

2009325170-An arrangement related to a gas sensor